NewcelX Ltd.
PublicNewcelX Ltd. is now publicly traded
The data on this page reflects NewcelX Ltd.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Seed Round
Jul 3, 2026
Total Funding Raised
$9.62M
Company Overview
NewcelX Ltd. operates in Healthcare and is based in Switzerland. It has raised $9.62M.
NewcelX Ltd. is a biotechnology company that develops transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases.
Sector
Healthcare
AI Layer
Non-AI
NewcelX Ltd. Comparables
Compare NewcelX Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Caspian Therapeutics, Inc. | 71% |
For institutional investors. Book with your work email.
NewcelX Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jul 3, 2026 | ||||
| Private Placement | Apr 27, 2026 | ||||
| Private Placement | Jun 27, 2025 | ||||
| Private Placement | Jan 7, 2025 | ||||
| Private Placement | Mar 20, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NewcelX Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.